The role of cardiac autonomic function in hypertension and cardiovascular disease - Current Hypertension Reports
- ️Julius, Stevo
- ️Fri May 15 2009
Julius S, Conway J: Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 1968, 38:282–288.
Julius S, Pascual AV, London R: Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971, 44:413–418.
Goldstein DS: Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983, 5:86–99.
Julius S, Krause L, Schork N, et al.: Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991, 9:77–84.
Palatini P, Vriz O, Nesbitt S, et al.: Parental hyperdynamic circulation predicts insulin resistance in offspring: the Tecumseh Offspring Study. Hypertension 1999, 33:769–774.
Grassi G: Role of the sympathetic nervous system in human hypertension. J Hypertens 1998, 16:1979–1987.
Schork NJ, Weder AB, Schork MA, et al.: Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Stat Med 1990, 9:301–314.
Masuo K, Kawaguchi H, Mikami H, et al.: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474–480.
Julius S, Nesbitt S: Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 1996, 9:113s–120s.
Jennings GL: Noradrenaline spillover and microneurography measurements in patients with primary hypertension. J Hypertens 1998, 16(Suppl):S35–S38.
Kjeldsen SE, Zweifler AJ, Petrin J, et al.: Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoreceptor responsiveness. Blood Press 1994, 3:164–171.
Esler M: The sympathetic system and hypertension. Am J Hypertens 2000, 13:99S–105S.
Palatini P, Majahalme S, Amerena J, et al.: Determinants of left ventricular structure and mass in young subjects with sympathetic over-activity. The Tecumseh Offspring Study. J Hypertens 2000, 18:769–775.
Palatini P, Longo D, Zaetta V, et al.: Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity. J Hypertens 2006, 24:1375–1381.
Maver J, Strucl M, Accetto R: Autonomic nervous system activity in normotensive subjects with a family history of hypertension. Clin Auton Res 2004, 14:369–375.
Mancia G, Grassi G, Giannattasio C, Seravalle G: Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999, 34:724–728.
Neumann SA, Jennings JR, Muldoon MF, Manuck SB: White-coat hypertension and autonomic nervous system dysregulation. Am J Hypertens 2005, 18:584–588.
Fagard RH, Stolarz K, Kuznetsova T, et al.: Sympathetic activity, assessed by power spectral analysis of HR variability, in white-coat, masked, and sustained hypertension versus true normotension. J Hypertens 2007, 25:2280–2285.
Calhoun DA, Mutinga ML, Wyss JM, Oparil S: Muscle sympathetic nervous system activity in black and Caucasian hypertensive subjects. J Hypertens 1994, 12:1291–1296.
Flaa A, Mundal HH, Eide I, et al.: Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension 2006, 47:396–402.
Lund-Johansen P: Newer thinking on the hemodynamics of hypertension. Curr Opin Cardiol 1994, 9:505–511.
Julius S: The blood pressure seeking properties of the central nervous system. J Hypertension 1988, 6:177–185.
Palatini P, Julius S: Heart rate and the cardiovascular risk. J Hypertens 1997, 15:3–17.
Palatini P, Benetos A, Grassi G, et al.: Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006, 24:603–610.
Levy RL, White PD, Stroud WD, Hillman CC: Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945, 129:585–588.
Dyer AR, Persky V, Stamler J, et al.: Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiological studies. Am J Epidemiol 1980, 112:736–749.
Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987, 113:1489–1494.
Mancia G, Bertinieri G, Grassi G, et al.: Effects of blood pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 1983, 2(8352):695–697.
Mancia G, Ferrari A, Gregorini L, et al.: Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983, 53:96–104.
Julius S, Jamerson K, Mejia A, et al.: The association of borderline hypertension with target organ changes and higher coronary risk: Tecumseh Blood Pressure Study. JAMA 1990, 264:354–358.
Smith SD, Julius S, Jamerson K, et al.: Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. Hypertension 1994, 12:455–462.
Palatini P, Casiglia E, Pauletto P, et al.: Relationship of tachycardia with high blood pressure and metabolic abnormalities. A study with mixture analysis in three populations. Hypertension 1997, 30:1267–1273.
Deibert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man. J Clin Invest 1980, 65:717–721.
Zeman RJ, Ludemann R, Easton TG, Etlinger JD: Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta-2-receptor agonist. Am J Physiol 1988, 254:E726–E732.
Flaa A, Aksnes TA, Kjeldsen SE, et al.: Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 2008, 57:1422–1427.
Jamerson KA, Julius S, Gudbrandsson T, et al.: Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993, 21:618–623.
Juhlin-Dannfelt A, Frisk-Holmberg M, Karlsson J, Tesch P: Central and peripheral circulation in relation to muscle-fibre composition in normo- and hyper-tensive man. Clin Sci (Lond) 1979, 56:335–340.
Tarazi RC, Frohlich ED, Dustan HP: Plasma volume in men with essential hypertension. N Engl J Med 1968, 278:762–765.
Cohn JN: Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. Clin Sci 1966, 30:267–278.
Julius S, Pascual AV, Abbrecht P, London R: Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med 1972, 140:982–985.
Julius S, Li Y, Brant D, et al.: Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension 1989, 13:422–429.
Hartford M, Wikstrand J, Wallentin I, et al.: Left ventricular mass in middle-aged men. Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors. Clin Exper Hypertens 1983, 5:1429–1451.
Lantelme P, Milon H, Gharib C, et al.: White coat effect and reactivity to stress: cardiovascular and autonomic nervous system responses. Hypertension 1998, 31:1021–1029.
Landsberg L: A teleological view of obesity, diabetes and hypertension. Clin Exp Pharmacol Physiol 2006, 33:863–867.
Kannel WB, Brand N, Skinner JJ Jr, et al.: The relation of adiposity to blood pressure and development of hypertension. Ann Intern Med 1967, 67:48–59.
Julius S, Valentini M, Palatini P: Overweight and hypertension: a 2-way street? Hypertension 2000, 35:807–813.
Stein CM, Nelson R, Deegan R, et al.: Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995, 96:579–585.
Valentini M, Julius S, Palatini P, et al.: Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens 2004, 22:1999–2006.
Narkiewicz K, Phillips BG, Kato M, et al.: Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005, 45:522–525.
Hogarth AJ, Mackintosh AF, Mary DA: Gender-related differences in the sympathetic vasoconstrictor drive of normal subjects. Clin Sci (Lond) 2007, 112:353–361.
Hogarth AJ, Burns J, Mackintosh AF, Mary DA: Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men. J Hum Hypertens 2008, 22:544–549.
Palatini P: Heart rate as a cardiovascular risk factor: Do women differ from men? Ann Med 2001, 33:213–221.